1. Introduction {#sec1}
===============

Due to the exceptional optical and electrical behavior of the group II--VI elements of periodic table arising from quantum confinements of electrons and large surface area, much research has been conducted on novel nanomaterials over the last several years. Nanoscale materials, i.e., quantum dots (QDs) containing the above mentioned group elements possess a number of promising characteristics, i.e., (i) strong fluorescence emission and optical stability; (ii) broad range excitation wavelength; (iii) better quantum yield (QY); and (iv) tunable emission peak ranging from the ultraviolet to the infrared region. These exceptional properties provide tremendous potential for interdisciplinary research among nanotechnologists, bioengineers, physicists, and chemists, as well as cooperation between academic research and industrial production ([@bib8]; [@bib9]; [@bib20]; [@bib22]).

A huge number of different QDs has been reported and extensively investigated containing the elements of II & VI group ([@bib10]; [@bib13]; [@bib21]; [@bib23]; [@bib25]; [@bib29]; [@bib36]; [@bib43]). Though those QDs are envisioned as a promising class of nanocrystals and have significant interest because of excellent photostability and changeable emission properties, the problems associated with cadmium-, indium-, selenium-, and arsenic-based QDs are their inherent conflicting reports on their toxicity, which has hampered their extended validation in clinical trials for use in humans ([@bib3]; [@bib11]; [@bib24]; [@bib40]; [@bib42]). Biocompatible and water dispersible QDs are preferred for biological applications and also due to environmental disposal requirements. Only few efforts have been made recently to prepare biocompatible QDs ([@bib12]; [@bib14]; [@bib19]; [@bib27]; [@bib31]; [@bib32]; [@bib34]; [@bib45]). In spite of the approaches to making biocompatible QDs, a few issues such as scalability remain to be resolved; for example, living organisms that can produce QDs has the drawback of high-throughput production. Furthermore, the functionalization of QDs with biocompatible molecules may cause a loss of quantum yield, and is also a multistep preparative process. Hence, a one-step QD synthesis process with biocompatible properties is urgently needed.

The introduction of chiral QDs\' with induced optical chirality and fluorescent emission at both visible and infrared ranges would significantly benefit the development of numerous biosensing and bioimaging applications. The chirality of nanomaterials has recently been explored in modern nanoscience as an alternative to natural chiral molecules due to the former\'s excellent photostability, thermal stability, biocompatibility, and low toxicity. These properties open new possibilities in catalysis, chiral sensing, optical communications systems and imaging applications, and metamaterials in advanced optical devices ([@bib3]; [@bib6]; [@bib16]; [@bib33]; [@bib35]; [@bib37]; [@bib41]; [@bib47]; [@bib44]).

Zirconium, a group IVB transition metal element, has been applied in different technological applications, for example, in catalysis, fuel cells, and the biomedical field due to its nontoxicity, ability to capture UV light capture, thermal stability, and mechanical strength. Advancement of nanotechnology has introduced Zr at the nanoscale dimension with peculiar size-dependent physical and chemical properties because of large surface area and the confinement of electronic states compared to its bulk regime ([@bib26]; [@bib30]; [@bib38]; [@bib39]). However, despite a few studies on the synthesis and characterization of zirconium nanoparticles (Zr NPs), till date there has been no report on the synthesis of zirconium quantum dots (Zr QDs). It is expected that Zr QDs will bring new opportunities in not only in optics arena but also in other diverse research sector.

Herein, we have reported a one-step conversion of Zr NPs to chiral Zr QDs with the assistance of an autoclave. The synthesized Zr QDs showed blue fluorescence emission as well as demonstrated aqueous dispersibility, and was further applied in the biosensing of infectious bronchitis virus (IBV).

Respiratory disease in chickens caused by Infectious bronchitis virus (IBV) consisting of several physical symptoms and can replicate in the oviduct of infected birds, resulting in reduced egg production and fertility. IBV strains affects the chicken\'s kidneys, causing significant mortality. Most importantly, the emergence of new IBV variants every year remains a serious problem for the poultry industry and global economy ([@bib2]; [@bib18]). Hence, IBV was chosen as a model analyte to develop a fluorescence based sensor integrated with nanotechnology for rapid detection.

2. Materials and methods {#sec2}
========================

Zirconium nanoparticles, HAuCl~4~.3H~2~O, 3,3ʹ,5,5ʹ-tetramethylbenzidine (TMB), 3-mercaptopropionic acid, bovine serum albumin (BSA), H~2~O~2~, and 96-well plates were purchased from Sigma-Aldrich (St. Louis, MO, USA). Ascorbic acid was received from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Highly pure deionized (DI) water (\>18 MΩ·cm) was used in all the experiments.

2.1. Synthesis of Zr QDs {#sec2.1}
------------------------

1 mL (0.1 M) solution of ascorbic acid was mixed with Zr NPs (0.5 mg/mL, 20 mL) and autoclave for 1h at 150 °C. Then, the synthesized QD solution was kept at room temperature for cooling down.

2.2. MTT assay {#sec2.2}
--------------

To demonstrate the toxicity of Zr QDs against cells, cytotoxicity was evaluated by Methylthiazolyldiphenyl-Tetrazolium (MTT) assay in this study. C6 glioma cells (2 × 10^4^ cells per mL) were obtained from Korean Cell Line Bank (Seoul, Korea) and was cultivated in 96-well plates. After 24 h, particles were added into the wells at a series of dilution factors. After twenty-four hours of incubation, supernatants of cells were removed, then 100 μL of media and MTT solution (10 μL) were added to the cell culture plate for 4 h. A total of 10% Sodium dodecyl sulfate (SDS; IBS-BS003a, Intron Biotechnology, Seongnam, Gyeonggi-do, Korea) solution (100 μL) with 0.2% of hydrochloric acid was added to the cell culture plate and remained in the dish for 18 h.

2.3. Synthesis of spiky magnetoplasmonic nanoparticles (MP NPs) {#sec2.3}
---------------------------------------------------------------

Water-soluble MP NPs were prepared based on the previously reported method ([@bib46]). Briefly, 400 μL solution of as-prepared smooth gold nanoparticle (Au NPs)--coated Fe~3~O~4~, 1% aqueous solution of trisodium citrate (22 μL), and hydroquinone solution (1 mL, 30 mM) were added sequentially to a HAuCl~4~ solution (0.25 mM, 10 mL) for 30 min at 25 °C. Here, Fe~3~O~4~\@Au NPs core-shell structured particles served as seeds, and Au^3+^ ions were reduced on it with the addition of the hydroquinone.

2.4. The culture of IBV {#sec2.4}
-----------------------

The procedures of propagation and titration of virus was followed as previously described ([@bib17]; [@bib18]). The concentration of the stock solution was 1 × 10^6^ EID~50~/mL.

2.5. Specificity of antibodies toward bronchitis virus (IBV) {#sec2.5}
------------------------------------------------------------

The conventional ELISA was performed for the specificity of the IBV antibodies to IBV. 50 μL (1 × 10^3^ EID~50~/mL) virus solutions were kept on polystyrene plate at 4 °C for 8h. Then, after rinsed, blocking agents was added for 1h. Then, anti-IBV Ab (1 μg/mL), anti-H5N2Ab (1 μg/mL), anti-H4 Ab (1 μg/ml), and anti-H5N1Ab (1 μg/mL) were added to the wells, incubated at 25 °C for 1 h. HRP-conjugated secondary antibody (50 μL, 1 μg/mL) was added for 1h. At last, TMB (10 nM)/H~2~O~2~ (5 nM) solution was mixed to all well (50 μL/well) for 10 min. 10% H~2~SO~4~ solution (50 μL/well) was used to stop the reaction.

2.6. Conjugation of anti-IBV antibodies with Zr QDs {#sec2.6}
---------------------------------------------------

Electrostatic force was used to bind between IBV--specific antibodies and Zr QDs. A mixture of PLL (200 μL) and QDs (800 μL) was kept for 1 h at 25 °C. Zr QDs will be covered by PLL in this step. The anti-IBV antibody (1 μg/mL) added on this solution for 1h. Antibodies will bind with PLL at this stage. 1 ng/mL (50 μL) of anti-mouse IgG-HRP was added to all well for 1 h. Upon adding of 100 μL TMB solution for 20 min, blue colored solution was appeared.

2.7. Conjugation of anti-IBV antibodies and MP NPs {#sec2.7}
--------------------------------------------------

To bind MP NPs with antibodies, 100 μL solution of 3-mercaptopropionic acid (MPA) (10 mM) was mixed with MP NPs (900 μL) and gently stirred at room temperature for an hour. Then the mixture was separated through centrifugal force (4,500 rpm, 30 min) and redispersed on PBS buffer (pH 7.5, 1 mL). At this stage, the carboxylic group will be covered on the surface of MP NPs. To make a conjugation between MP NPs and anti-IBV antibodies, MP NPs (1 mL)was mixed with EDC (4 mM), NHS (10 mM) and 1 μL anti-IBV antibodies (1 μg/mL) for 1 h.

3. Results & discussions {#sec3}
========================

In this study, we have reported a two-step way of hetero structuring magnetoplasmonic and fluorescent nanocrystals through immunoreaction for IBV detection. Firstly, ZrQDs and MP NPs were prepared, then antibodies was conjugated with nanomaterials ([Fig. 1](#fig1){ref-type="fig"}A--D). ZrQDs and MP NPs will stay apart from each other since no attraction between them at this point. Antibody-conjugated ZrQDs and MP NPs will come closer and will make a magnetoplasmonic-fluorescent nanohybrids structure while target analyte was added ([Fig. 1](#fig1){ref-type="fig"}E). Then, external magnet can be used to separate nanostructured magnetoplasmonic-fluorescent ([Fig. 1](#fig1){ref-type="fig"}F & G), and the photoluminescence (PL) intensity of nanohybrids can be used to measure the analyte\'s concentration ([Fig. 1](#fig1){ref-type="fig"}H).Fig. 1Scheme of sensor design: (A) Zr nanoparticles and reducing agent keep on vial; (B) Zr QDs formation; (C) antibody conjugated QDs; (D) the addition of antibody-conjugated MP NPs; (E) formation of nanostructured magnetoplasmonic-fluorescent with the addition of target, then separated (F); (G) the nanohybrid-conjugated part was dispersed and measure the optical properties (H).Fig. 1

The fluorescence and absorbance spectra of Zr QDs were appeared at 412 nm and 378 nm, respectively ([Fig. 2](#fig2){ref-type="fig"}A & B). As-prepared Zr QDs showed chiral peak at 352 nm ([Fig. 2](#fig2){ref-type="fig"}C). Zr QDs showed light yellow color at daylight, and blue under UV-light ([Fig. 2](#fig2){ref-type="fig"}D).Fig. 2Optical properties of Zr QDs: (A) PL intensity and absorbance spectra of Zr QDs (B); (C) chiral spectra and (D) color of solution.Fig. 2

The quantum yield value of the synthesized Zr QDs was 9.16 % and the fluorescence lifetime was 1.92 ns.

Zr QDs synthetic route was shown in [Fig. 3](#fig3){ref-type="fig"}A. After synthesis of Zr QDs, FEI Titan 8-300 TEM machine was used to take HRTEM of Zr NPs and QDs. As shown in [Fig. 3](#fig3){ref-type="fig"}B, the Zr NPs were approximately 15--20 nm in size. A far image of as Zr QDs showed that the QDs size was 2--3 nm ([Fig. 3](#fig3){ref-type="fig"}C). HRTEM image revealed Zr QDs contained lattice spacing of 0.2821 nm, indicating (100) lattice planes of the Zr ([Fig. 3](#fig3){ref-type="fig"}D) ([@bib5]).Fig. 3Image of Zr QDs and Zr NPs: (A) Scheme of Zr QD synthesis; (B) HRTEM image of ZrNPs and QDs (C) (inset: size distribution profile); (D) HRTEM image of Zr QDs (inset: lattice pattern of ZrQDs).Fig. 3

[Fig. 4](#fig4){ref-type="fig"} shows the XPS spectrum of Zr NPs ([Fig. 4](#fig4){ref-type="fig"}A) and QDs ([Fig. 4](#fig4){ref-type="fig"}B). A peak of Zr 3d~3/2~ and Zr 3d~5/2~ were appeared in all the samples. In Zr NPs, the Zr 3d peaks were observed at 185.4 ev for 3d~5/2~ and 187.7 ev for 3d~3/2~, as shown in [Fig. 4](#fig4){ref-type="fig"}A ([@bib4]; [@bib7]; [@bib28]). However, the peaks of Zr 3d~3/2~ and Zr 3d~5/2~ were slightly shifted for Zr QDs, probably due to the change and coupling of electronic state.Fig. 4XPS data of Zr NPs (A) and Zr QDs (B).Fig. 4

The crystallinity of Zr QDs was analyzed by XRD spectroscopy and shown in [Fig. 5](#fig5){ref-type="fig"}. It is clear from [Fig. 3](#fig3){ref-type="fig"} that as-synthesized Zr QDs contain two crystalline phases: a monoclinic phase, marked with the red squares, and a tetragonal phase, marked with the blue squares. Zr QDs contain a higher component of the monoclinic than the tetragonal phase. The peak positions of Zr QDs and ZrO~2~ are shifted a little bit ([@bib4]; [@bib15]), probably, due to the crystal defects formed during synthesis.Fig. 5X-ray diffraction (XRD) spectra of synthesized Zr QDs.Fig. 5

The cytotoxicity of as-prepared Zr QDs was performed on C6 glioma cells using MTT assay. As shown in [Fig. 6](#fig6){ref-type="fig"}, no obvious cytotoxicity effects on C6 glioma cells was observed with 0.125 times dilution of Zr QDs compared with the control group. In this study, we performed the nanotoxicity effects of Zr QDs without surface modification. Insightful cytotoxicity study of as-prepared Zr QDs may be needed with surface modification with different biomolecules and their application on different cells in near future.Fig. 6Cell viability study of Zr QDs.Fig. 6

Transmission electron microscopy (TEM) images of spiky magneto-plasmonic nanoparticles are shown in [Fig. 7](#fig7){ref-type="fig"}A. The average size of particles was around 50 nm. Magnified close-up TEM image showed the surface of the MP NPs containing spiky tips of approximately 10 nm in size ([Fig. 7](#fig7){ref-type="fig"}B). Naked eye color of solution was showed at the inset of [Fig. 7](#fig7){ref-type="fig"}B. The broadened plasmonic peak of the MP NPs was located at 598 nm ([Fig. 7](#fig7){ref-type="fig"}C). The SQUID measurement of MP NPs has shown in [Fig. 7](#fig7){ref-type="fig"}D. The magnetic saturation value of MP NPs observed at 60.0 emug^−1^.Fig. 7Characterization of MP NPs: (A) Large-scale TEM image of MP NPs; (B) close-up view of MP NPs (inset: color of solution); (C) the absorbance spectra of MP NPs; and (D) the SQUID measurement of MP NPs.Fig. 7

The specificity of anti-IBV antibodies toward the target IBV was shown in [Fig. 8](#fig8){ref-type="fig"}. A higher absorbance value of anti-IBV antibodies in comparison to others tells that anti-IBV antibodies have a strong binding affinity toward the target IBV.Fig. 8The specificity of anti-IBV antibodies for coronavirus.Fig. 8

Anti-IBV antibodies binding with MP NPs and Zr QDs was shown [Fig. 9](#fig9){ref-type="fig"}. A higher absorbance value for anti-IBV antibodies with nanomaterials indicates the confirmation of binding between antibodies and nanomaterials. Also, the change of zeta potential value further supported the conjugation of antibodies with QDs ([Table 1](#tbl1){ref-type="table"}).Fig. 9The conjugation of antibodies with nanomaterials.Fig. 9Table 1Step by step analysis of zeta potential value.Table 1Zeta potential (mV)Zr QDsAfter conjugation with Poly-*l*-lysine (PLL)After conjugation with antibodies−13.32+8.07--1.97

FTIR spectrum analyzed for the amide bond formation between antibodies and MP ([Fig. 10](#fig10){ref-type="fig"}). The peak at 3500--3700 cm^−1^ and 1630--1690 cm^−1^ corresponds the N--H stretching and C=O stretching of amide bond respectively.Fig. 10FTIR spectra of MP NPs and anti-IBV antibodies binding.Fig. 10

The fluorescence intensity of immune-linked magnetoplasmonic-fluorescent nanohybrids increased approximately 25% in comparison to antibody-conjugated Zr QDs ([Fig. 11](#fig11){ref-type="fig"}A). The change in fluorescence intensity at different concentrated virus solution was investigated ([Fig. 11](#fig11){ref-type="fig"}B and C). The PL intensity changes with the different concentrations of virus solution was linearly responds in the range of 10,000 EID/50 μL to 100 EID/50 μL with an LOD value of 79.15 EID/50 μL.Fig. 11Fluorescence-based detection of IBV: (A) PL intensity responses; (B) Target virus concentration dependent PL intensity; (C) PL intensity Vs virus concentration curve; and (D) selectivity test.Fig. 11

The selectivity of the proposed bioassay was examined with other virus strains, namely H5N1, H5N2, H9N2, H4N6, and FAdV. A significant difference of fluorescence intensity was observed with the target IBV compare to others, indicating that the proposed assay is highly selective for the target analyte ([Fig. 11](#fig11){ref-type="fig"}D).

The sensitivity of this assay was compared with the ELISA method ([Table 2](#tbl2){ref-type="table"}). The colorimetric response of IBV using ELISA was 1000 EID/50 μL, tells us that the proposed fluorescence assay is 10 times more sensitive than ELISA.Table 2A comparison study of IBV detection.Table 2MethodConcentration (EID/50 μL)10000500010005001005010This study+++++−−Conventional ELISA+++−−−−

In this study, we have introduced aqueous soluble chiral Zr QDs for the first time. There is still much to be learned about the nature of Zr QDs, such as how excitonic properties arise on it, it\'s size-tunable optical properties, surface modification with different biological molecules, and the control of the interaction between Zr QDs and plasmonic metals.

4. Conclusions {#sec4}
==============

Here, we have presented a new nanocrystal synthesis method---i.e., Zr QDs---and a series of characterizations was performed to check the nanocrystals\' optical properties, morphology, and practicability in biological applications. Furthermore, a bioassay was proposed to achieve enhanced sensitivity for IBV detection using as-prepared Zr QDs and MP NPs in blood media, which showed greater sensitivity than conventional ELISA methods. Most importantly, the introduction of novel QDs synthesis and an optical--based bioassay may open new doors for research and further optical applications.
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